MOD GRF 1-29 (2MG)
Peptides Australia MOD GRF 1-29
CJC 1295 DAC Chemistry

MOD GRF 1-29 (2MG)

AUD $75.00

 

Note: Products are for laboratory research use only. Not for human use. Reference Materials are not therapeutics and we do not sell to patients.

 

Out of stock

Category:
000
CAS 863288-34-0
Molar Mass 3367.89 g/mol
Chemical Formula C152H252N44O42
IUPAC Name DL-tyrosyl-DL-alanyl-DL-alpha-aspartyl-DL-alanyl-DL-isoleucyl-DL-phenylalanyl-DL-threonyl-DL-glutaminyl-DL-seryl-DL-tyrosyl-DL-arginyl-DL-lysyl-DL-valyl-DL-leucyl-DL-alanyl-DL-glutaminyl-DL-leucyl-DL-seryl-DL-alanyl-DL-arginyl-DL-lysyl-DL-leucyl-DL-leucyl-DL-glutaminyl-DL-alpha-aspartyl-DL-isoleucyl-DL-leucyl-DL-seryl-DL-argininamide
Synonyms Mod GRF(1-29), Modified GRF 1-29, CJC1295 without DAC, CJC-1295 No DAC
Storage Lyophilized protein is to be stored at -20°C. Reconstituted protein can be stored at 4°C.
Physical Form Lyophilized Powder
Standard 2MG
Terms of sale This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Information presented is based upon evidence found in clinical studies. Please familiarise yourself with our Terms & Conditions prior to ordering.

MOD GRF 1-29 is a Growth Hormone Releasing Hormone (GHRH). When the drug was first created, its major function was to was to boost protein synthesis to increase muscle tissue growth.
It is also considered beneficial in assisting in athletics performance, speeding up recovery, burning of fat, increasing bone density and repairing of skin and organ cells.
MOD GRF 1-29 is CJC-1295 but without the Drug Affinity Complex (DAC). MOD GRF 1-29 is a modified and simplified version of Sermorelin. Sermorelin has an extremely short half-life, which is why it has been modified into MOD GRF 1-29 to extend its biological activity to reduce metabolic clearance.

In Vivo:
As MOD GRF 1-29 has a half life of around 30 minutes, it was concluded in studies that dosage of around 100mcg to 300mcg, 1-3 x a day gives best results.

Studies and additional info:
https://www.ncbi.nlm.nih.gov/pubmed/26771670
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205513/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832931/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038486/
https://www.ncbi.nlm.nih.gov/pubmed/18793574/

Related products